Novartis Delivered Solid 2016 Performance, Alcon Q4 Sales Flat

Sales were in line with last fiscal year due to strong performances from growth products (Cosentyx, Entresto, Gilenya, oncology, Sandoz...

Read More

Novartis to Acquire Presbyopia Drug Developer Encore Vision

Novartis Ophthalmology announced they have entered into an agreement to acquire a topical treatment for presbyopia from Encore Vision Inc, a...

Read More

Novartis on Alcon: All Options are Open

Reuters reported yesterday, that Swiss parent of Alcon, drugmaker Novartis is considering the sale of its eye care unit Alcon  The source is an...

Read More

Alcon Replaces CEO and Restructures After Poor Earnings Report

Following reports of plummeting sales from Alcon’s eye-care unit and news that Novartis will miss its Q4 earnings estimates, Alcon executive Jeff...

Read More

Novartis Considering Selling Alcon’s CL Care Business

Bloomberg News is reporting that Novartis is considering selling Alcon’s contact lens care product business While Alcon’s revenues as a whole...

Read More